GNAS mutation was present in 80 (51 %) of 157 IPMN patients with invasive adenocarcinoma, whereas 265 (59 %) of 446 IPMNs without adenocarcinoma. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.